STAT6 and breast carcinoma: It has been reported that AS can inhibit tumor growth and early liver metastasis in a 4T1 mammary carcinoma mouse model by inhibiting TAM-induced pro-tumorigenic and pro-metastatic activities via STAT6 [48].